SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Colombia
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

ABBOTT .S.A

Main Activities: Farm Product Raw Material Merchant Wholesalers

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Abbott Laboratories de Colombia S A

Headquarters
Cl 100 9a 45 Piso 14; Bogota D.C; Bogota D.C
Status: Non-Listed
Legal Form: Public Limited Company
Operational Status: Operational
Fiscal ID (NIT): 860002134
Incorporation Date: November 21, 1944
Total Employees: 324

Tel: +57-1-6285600

Company Description

Abbott Laboratories in Colombia is a subsidiary of the multinational company Abbott, created more than 100 years in Illinois. In Colombia`s corporate purpose is the discovery of new medicines, new technologies and new ways to manage health. Has products covering everything related to health care, from nutritional products and laboratory diagnostics to medical devices and pharmaceutical therapies. Its products more recognized areEnsure and Pediasure

Company Analysis

According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues increased with 0.72%, from COP 437,492,734 thousands to COP 440,643,609 thousands. Operating result increased from COP 62,975,454 thousands to COP 63,825,826 thousands which means 1.35% change. The results of the period increased 13.07% reaching COP 45,850,485 thousands at the end of the period against COP 40,548,940 thousands last year. Return on equity (Net income/Total equity) went from 20.41% to 23.49%, the Return On Asset (Net income / Total Asset) went from 16.39% to 17.53% and the Net Profit Margin (Net Income/Net Sales) went from 9.27% to 10.41% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 33.99% compared to 24.59% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.34 to 3.64 when compared to the previous year.

Key Executives

Fonseca Saravia Juan Manuel Member of Board of Directors
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

261,584,491

247,475,854

Current Assets

XXX,XXX,XXX

XXX,XXX,XXX

Total Liabilities

XX,XXX,XXX

XX,XXX,XXX

Shareholders Equity

XXX,XXX,XXX

XXX,XXX,XXX

Current Liabilities

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in COP.
Income Statement

Total Operating Revenue

XXX,XXX,XXX

XXX,XXX,XXX

Operational Profit (Loss)

XX,XXX,XXX

XX,XXX,XXX

Net Profit (Loss)

XX,XXX,XXX

XX,XXX,XXX

* All the accounts are in COP.
Ratios
Profitability Ratios

Return on Assets (ROA)

XX.XX%

XX.XX%

Annualised Return on Assets (ROA)

XX.XX%

XX.XX%

Return on Equity (ROE)

XX.XX%

XX.XX%

Annualised Return on Equity (ROE)

XX.XX%

XX.XX%

Return on Sales (ROS)

XX.XX%

X.XX%

Return on Capital

XX.X%

XX.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

XX.XX%

XX.XX%

Efficiency Ratios

Accounts Receivable Turnover

X.XXx

X.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

X.XXx

XX.XXx

Asset Turnover

X.XXx

X.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XX,XXX,XXX

XX,XXX,XXX

EBITDA

XX,XXX,XXX

XX,XXX,XXX

Bookvalue (BV)

XXX,XXX,XXX

XXX,XXX,XXX

Net Cash

XX,XXX,XXX

XX,XXX,XXX

Liquidity Ratios

Current Ratio

XXX.XX%

XXX.XX%

Quick ratio

XXX.XX%

XXX.XX%

Doom's day ratio

XX.XX%

XX.XX%

Cash Flow to Debt

XX.XX%

XXX.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Debt to equity

XX.XX%

XX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

X.XX%

X.XX%

Trend Ratios

Revenue Trend

XXX.XX%

XXX.XX%

Net Income Trend

XXX.XX%

-XXX.XX%

Operating Income Trend

XXX.XX%

-X,XXX.XX%